First-in-class treatment for renal cancer

Research unit

INNOSUISSE

Project number

44124.1 IP-LS

Project title

First-in-class treatment for renal cancer

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Category	Text
Short description (German)	First-in-class treatment for renal cancer
Short description (English)	First-in-class treatment for renal cancer
Abstract (German)	90 % of patients with advanced renal cancer are resistant to immunotherapy. Building on our innovative solution, this project will establish the use of first-in-class molecules targeting a novel resistance mechanism to improve the efficacy of immunotherapy in renal cancer.